Early Hemoglobin and Transfusion Trends from OPERA: a Real-World Study of Pegcetacoplan Treatment in US Adults with Paroxysmal Nocturnal Hemoglobinuria (HEM 2023) - Apellis Medical Hub

Early Hemoglobin and Transfusion Trends from OPERA: a Real-World Study of Pegcetacoplan Treatment in US Adults with Paroxysmal Nocturnal Hemoglobinuria

Share Via Email

Back to Conference Resources

PNH Congress Presentations International Congress on Hematologic Malignancies 2023

The following information is available for educational purposes only. The information is not to be re-purposed or re-used in its current form or presentation for any personal or professional use. Apellis reserves the right to withdraw, modify or change the information that is available on this website at any time.